These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6341730)

  • 1. Corticosteroids in the treatment of septic shock and the adult respiratory distress syndrome.
    Nicholson DP
    Med Clin North Am; 1983 May; 67(3):717-24. PubMed ID: 6341730
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome.
    Schein RM; Bergman R; Marcial EH; Schultz D; Duncan RC; Arnold PI; Sprung CL
    Chest; 1987 Jun; 91(6):850-4. PubMed ID: 3556054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids for septic shock and adult respiratory distress syndrome.
    Bone RC
    Prog Clin Biol Res; 1989; 308():857-65. PubMed ID: 2675073
    [No Abstract]   [Full Text] [Related]  

  • 4. High doses of corticosteroids in the treatment of septic shock.
    Hellman A; Alestig K
    Acta Chir Scand Suppl; 1985; 526():124-8. PubMed ID: 3911703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.
    Luce JM; Montgomery AB; Marks JD; Turner J; Metz CA; Murray JF
    Am Rev Respir Dis; 1988 Jul; 138(1):62-8. PubMed ID: 3202402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroids for septic shock: back from the dead? (Pro).
    Balk RA
    Chest; 2003 May; 123(5 Suppl):490S-9S. PubMed ID: 12740234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.
    Annane D; Pastores SM; Rochwerg B; Arlt W; Balk RA; Beishuizen A; Briegel J; Carcillo J; Christ-Crain M; Cooper MS; Marik PE; Umberto Meduri G; Olsen KM; Rodgers S; Russell JA; Van den Berghe G
    Intensive Care Med; 2017 Dec; 43(12):1751-1763. PubMed ID: 28940011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adult respiratory distress syndrome in patients with infection].
    Ivashkin VT; Alekseev VG; Moshiashvili VI; Sinopal'nikov AI; Kozlovskiĭ IA; Zhuravlev VI; Abrosimov AV
    Klin Med (Mosk); 1992; 70(3-4):24-7. PubMed ID: 1507839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.
    Marks JD; Marks CB; Luce JM; Montgomery AB; Turner J; Metz CA; Murray JF
    Am Rev Respir Dis; 1990 Jan; 141(1):94-7. PubMed ID: 2297191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [20th consensus conference on intensive care and emergency medicine (Corticosteroids in the treatment of septic shock and respiratory distress syndrome].
    Charbonneau P
    Rev Mal Respir; 2001 Apr; 18(2):101-2. PubMed ID: 11424704
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial design in studies of corticosteroids for bacterial infections.
    Weitzman S; Berger S
    Ann Intern Med; 1974 Jul; 81(1):36-42. PubMed ID: 4366291
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation in septic shock. Effect of pentoxifylline.
    Ambrus JL; Halpern J; Mahafzah M; Sayyid S
    J Med; 1990; 21(1-2):121-8. PubMed ID: 2212866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
    Steinberg KP; Hudson LD; Goodman RB; Hough CL; Lanken PN; Hyzy R; Thompson BT; Ancukiewicz M;
    N Engl J Med; 2006 Apr; 354(16):1671-84. PubMed ID: 16625008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of evidence for the pharmacologic effectiveness of prolonged methylprednisolone treatment in unresolving ARDS.
    Meduri GU
    Chest; 1999 Jul; 116(1 Suppl):116S-118S. PubMed ID: 10424629
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of plasma proinflammatory cytokines in malaria-related ARDS treated with corticosteroids.
    Hiekkanen T; Skogberg K; Pettilä V
    Intensive Care Med; 2001 Nov; 27(11):1823-4. PubMed ID: 11810129
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroids for septic shock: back from the dead? (Con).
    Sessler CN
    Chest; 2003 May; 123(5 Suppl):482S-9S. PubMed ID: 12740233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucocorticoids and immunoglobulins in an acute respiratory distress syndrome secondary to varicella pneumoniae].
    Bautista Rodríguez MD; Bravo-Rodríguez Fde A; Fuentes Jiménez F; Sancho Ruiz H
    Med Clin (Barc); 2004 Feb; 122(6):238. PubMed ID: 15012896
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid therapy of septic shock: the decision is in the eye of the beholder.
    Dellinger RP
    Crit Care Med; 2008 Jun; 36(6):1987-9. PubMed ID: 18520670
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring the role of etomidate in septic shock and acute respiratory distress syndrome.
    Bloomfield R; Noble DW
    Crit Care Med; 2006 Jun; 34(6):1858; author reply 1858-9. PubMed ID: 16715011
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
    Annane D; Sébille V; Bellissant E;
    Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.